Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as GBX 5 ($0.06) and last traded at GBX 10.87 ($0.14), with a volume of 788720 shares trading hands. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Trading Down 27.6 %
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 196.67. The stock has a market capitalization of £6.66 million, a PE ratio of -1.36 and a beta of -0.26. The stock has a 50 day moving average price of GBX 18.32 and a 200-day moving average price of GBX 22.74.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- Stock Market Upgrades: What Are They?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Stock Splits, Do They Really Impact Investors?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
